The EVA (Early Vascular Aging) Study: Association of Central Obesity With Worse Arterial Health After Preeclampsia

Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Journal of the American Heart Association Ročník 12; číslo 21; s. e031136
Hlavní autoři: Paquin, Amélie, Werlang, Ana, Coutinho, Thais
Médium: Journal Article
Jazyk:angličtina
Vydáno: England John Wiley and Sons Inc 07.11.2023
Wiley
Témata:
ISSN:2047-9980, 2047-9980
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial health after preeclampsia remains unclear. Our objective was to evaluate the effect of CO and previous preeclampsia on arterial hemodynamics. Methods and Results We studied 40 women with previous preeclampsia (<6 years) and 40 age-matched controls with previous normotensive pregnancy in the same timeframe. We estimated arterial hemodynamics with validated techniques combining applanation tonometry and echocardiography. CO was defined as a waist-to-hip ratio ≥0.85. Differences in arterial hemodynamics across the 3 groups (preeclampsia with CO, preeclampsia without CO, and controls) were assessed with multivariable linear regression models adjusted for potential confounders. Twenty-six (65%) of the participants with preeclampsia had CO compared with 18 (45%) controls. Mean waist-to-hip ratio in patients with preeclampsia with CO, those with preeclampsia and no CO, and controls was 0.94±0.05, 0.80±0.04, and 0.83±0.07, respectively. In multivariable analyses, women with preeclampsia and CO had higher central blood pressure, arterial stiffness (carotid-femoral pulse wave velocity), steady arterial load (systemic vascular resistance), and wave reflections (reflected pressure wave amplitude, augmentation index) compared with controls ( <0.05 for each). Fewer hemodynamic domains were altered in the preeclampsia with no CO group, with higher central diastolic blood pressure, systemic vascular resistance, and wave reflections than controls ( <0.05). Conclusions Women with previous preeclampsia who also experience CO have the greatest alterations in arterial health and hemodynamics. Patients with preeclampsia with CO may represent a higher-risk subgroup who could be targeted for risk stratification and primary prevention of cardiovascular disease.
AbstractList Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial health after preeclampsia remains unclear. Our objective was to evaluate the effect of CO and previous preeclampsia on arterial hemodynamics. Methods and Results We studied 40 women with previous preeclampsia (<6 years) and 40 age-matched controls with previous normotensive pregnancy in the same timeframe. We estimated arterial hemodynamics with validated techniques combining applanation tonometry and echocardiography. CO was defined as a waist-to-hip ratio ≥0.85. Differences in arterial hemodynamics across the 3 groups (preeclampsia with CO, preeclampsia without CO, and controls) were assessed with multivariable linear regression models adjusted for potential confounders. Twenty-six (65%) of the participants with preeclampsia had CO compared with 18 (45%) controls. Mean waist-to-hip ratio in patients with preeclampsia with CO, those with preeclampsia and no CO, and controls was 0.94±0.05, 0.80±0.04, and 0.83±0.07, respectively. In multivariable analyses, women with preeclampsia and CO had higher central blood pressure, arterial stiffness (carotid-femoral pulse wave velocity), steady arterial load (systemic vascular resistance), and wave reflections (reflected pressure wave amplitude, augmentation index) compared with controls ( <0.05 for each). Fewer hemodynamic domains were altered in the preeclampsia with no CO group, with higher central diastolic blood pressure, systemic vascular resistance, and wave reflections than controls ( <0.05). Conclusions Women with previous preeclampsia who also experience CO have the greatest alterations in arterial health and hemodynamics. Patients with preeclampsia with CO may represent a higher-risk subgroup who could be targeted for risk stratification and primary prevention of cardiovascular disease.
Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial health after preeclampsia remains unclear. Our objective was to evaluate the effect of CO and previous preeclampsia on arterial hemodynamics. Methods and Results We studied 40 women with previous preeclampsia (<6 years) and 40 age‐matched controls with previous normotensive pregnancy in the same timeframe. We estimated arterial hemodynamics with validated techniques combining applanation tonometry and echocardiography. CO was defined as a waist‐to‐hip ratio ≥0.85. Differences in arterial hemodynamics across the 3 groups (preeclampsia with CO, preeclampsia without CO, and controls) were assessed with multivariable linear regression models adjusted for potential confounders. Twenty‐six (65%) of the participants with preeclampsia had CO compared with 18 (45%) controls. Mean waist‐to‐hip ratio in patients with preeclampsia with CO, those with preeclampsia and no CO, and controls was 0.94±0.05, 0.80±0.04, and 0.83±0.07, respectively. In multivariable analyses, women with preeclampsia and CO had higher central blood pressure, arterial stiffness (carotid‐femoral pulse wave velocity), steady arterial load (systemic vascular resistance), and wave reflections (reflected pressure wave amplitude, augmentation index) compared with controls (P<0.05 for each). Fewer hemodynamic domains were altered in the preeclampsia with no CO group, with higher central diastolic blood pressure, systemic vascular resistance, and wave reflections than controls (P<0.05). Conclusions Women with previous preeclampsia who also experience CO have the greatest alterations in arterial health and hemodynamics. Patients with preeclampsia with CO may represent a higher‐risk subgroup who could be targeted for risk stratification and primary prevention of cardiovascular disease.
Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial health after preeclampsia remains unclear. Our objective was to evaluate the effect of CO and previous preeclampsia on arterial hemodynamics. Methods and Results We studied 40 women with previous preeclampsia (<6 years) and 40 age-matched controls with previous normotensive pregnancy in the same timeframe. We estimated arterial hemodynamics with validated techniques combining applanation tonometry and echocardiography. CO was defined as a waist-to-hip ratio ≥0.85. Differences in arterial hemodynamics across the 3 groups (preeclampsia with CO, preeclampsia without CO, and controls) were assessed with multivariable linear regression models adjusted for potential confounders. Twenty-six (65%) of the participants with preeclampsia had CO compared with 18 (45%) controls. Mean waist-to-hip ratio in patients with preeclampsia with CO, those with preeclampsia and no CO, and controls was 0.94±0.05, 0.80±0.04, and 0.83±0.07, respectively. In multivariable analyses, women with preeclampsia and CO had higher central blood pressure, arterial stiffness (carotid-femoral pulse wave velocity), steady arterial load (systemic vascular resistance), and wave reflections (reflected pressure wave amplitude, augmentation index) compared with controls (P<0.05 for each). Fewer hemodynamic domains were altered in the preeclampsia with no CO group, with higher central diastolic blood pressure, systemic vascular resistance, and wave reflections than controls (P<0.05). Conclusions Women with previous preeclampsia who also experience CO have the greatest alterations in arterial health and hemodynamics. Patients with preeclampsia with CO may represent a higher-risk subgroup who could be targeted for risk stratification and primary prevention of cardiovascular disease.Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia. Central obesity (CO) is a risk factor for both preeclampsia and cardiovascular disease. Whether CO contributes to further worsening of arterial health after preeclampsia remains unclear. Our objective was to evaluate the effect of CO and previous preeclampsia on arterial hemodynamics. Methods and Results We studied 40 women with previous preeclampsia (<6 years) and 40 age-matched controls with previous normotensive pregnancy in the same timeframe. We estimated arterial hemodynamics with validated techniques combining applanation tonometry and echocardiography. CO was defined as a waist-to-hip ratio ≥0.85. Differences in arterial hemodynamics across the 3 groups (preeclampsia with CO, preeclampsia without CO, and controls) were assessed with multivariable linear regression models adjusted for potential confounders. Twenty-six (65%) of the participants with preeclampsia had CO compared with 18 (45%) controls. Mean waist-to-hip ratio in patients with preeclampsia with CO, those with preeclampsia and no CO, and controls was 0.94±0.05, 0.80±0.04, and 0.83±0.07, respectively. In multivariable analyses, women with preeclampsia and CO had higher central blood pressure, arterial stiffness (carotid-femoral pulse wave velocity), steady arterial load (systemic vascular resistance), and wave reflections (reflected pressure wave amplitude, augmentation index) compared with controls (P<0.05 for each). Fewer hemodynamic domains were altered in the preeclampsia with no CO group, with higher central diastolic blood pressure, systemic vascular resistance, and wave reflections than controls (P<0.05). Conclusions Women with previous preeclampsia who also experience CO have the greatest alterations in arterial health and hemodynamics. Patients with preeclampsia with CO may represent a higher-risk subgroup who could be targeted for risk stratification and primary prevention of cardiovascular disease.
Author Paquin, Amélie
Werlang, Ana
Coutinho, Thais
AuthorAffiliation 4 Department of Cardiovascular Medicine Mayo Clinic Rochester MN
1 Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada
3 Department of Obstetrics and Gynecology The Ottawa Hospital Ottawa ON Canada
2 Canadian Women’s Heart Health Centre University of Ottawa Heart Institute Ottawa ON Canada
AuthorAffiliation_xml – name: 1 Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada
– name: 3 Department of Obstetrics and Gynecology The Ottawa Hospital Ottawa ON Canada
– name: 2 Canadian Women’s Heart Health Centre University of Ottawa Heart Institute Ottawa ON Canada
– name: 4 Department of Cardiovascular Medicine Mayo Clinic Rochester MN
Author_xml – sequence: 1
  givenname: Amélie
  orcidid: 0000-0003-2034-4196
  surname: Paquin
  fullname: Paquin, Amélie
  organization: Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada, Canadian Women’s Heart Health Centre University of Ottawa Heart Institute Ottawa ON Canada
– sequence: 2
  givenname: Ana
  orcidid: 0000-0001-7979-1770
  surname: Werlang
  fullname: Werlang, Ana
  organization: Department of Obstetrics and Gynecology The Ottawa Hospital Ottawa ON Canada
– sequence: 3
  givenname: Thais
  orcidid: 0000-0002-7735-5315
  surname: Coutinho
  fullname: Coutinho, Thais
  organization: Division of Cardiology University of Ottawa Heart Institute Ottawa ON Canada, Canadian Women’s Heart Health Centre University of Ottawa Heart Institute Ottawa ON Canada, Department of Cardiovascular Medicine Mayo Clinic Rochester MN
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37929708$$D View this record in MEDLINE/PubMed
BookMark eNpVktFv2yAQxtHUae26Pu9t4rF7SArGBrOXyYqypVOlTlrXPqILPhIqx6RgT8p_Pzp3VQsSB3effgfie0-O-tAjIR85m3Mu-cWPZtXMeSHmTHAu5BtyUrBSzbSu2dGL_TE5S-me5SELJSr9jhwLpQutWH1C4s0W6fK2oedLiN2B3kKyYweRNhvfbz7TX8PYHr7QJqVgPQw-9DQ4usB-iNDR6zUmPxzonR-29C7EhLSJA0afayuELmcbl8_0Z0S0Hez2ycMH8tZBl_DsKZ6S39-WN4vV7Or6--WiuZrZkpfDDGANkmtVWyWsKKpCVqUqFMhKWrTCrSV3KAvBQTnWglBKMWGV5FnSWoXilFxO3DbAvdlHv4N4MAG8-ZcIcWMgDt52aJQV6FrG81qUuhW6lAC1Vlg75do1z6yvE2s_rnfY2un9r6CvK73fmk34YzjLdxa1yITzJ0IMDyOmwex8sth10GMYkynqWla6zjNLP71s9tzl_69lwcUksDGkFNE9Szgzj9Ywj9Yw2Rpmsob4C3hZqx4
Cites_doi 10.1161/circulationaha.109.914507
10.1016/j.jacc.2022.03.335
10.1136/bmj.i1753
10.1002/oby.20099
10.1038/jhh.2013.81
10.1007/s11936-018-0653-8
10.1016/0735-1097(92)90198-v
10.1161/circresaha.118.313276
10.1161/hypertensionaha.116.07907
10.1161/cir.0000000000000973
10.1093/ajh/hpaa183
10.1016/s0140-6736(06)68967-8
10.1161/circresaha.120.316101
10.1111/nure.12055
10.1161/circresaha.116.307547
10.1098/rspb.1922.0022
10.2174/1573402113666170413094319
10.1016/s0140-6736(05)67726-4
10.1161/hypertensionaha.110.157339
10.1152/ajpheart.00202.2020
10.1097/aog.0000000000003891
10.1093/eurheartj/ehl254
10.1111/j.1471-0528.2006.01180.x
10.1016/j.jacc.2010.11.058
10.1161/hypertensionaha.114.03285
10.1152/ajpheart.1986.251.3.H588
10.1093/eurheartj/ehq165
10.1093/eurheartj/ehm026
10.1161/circulationaha.109.886655
10.1371/journal.pone.0059371
10.3390/antiox12061295
10.1161/jaha.115.002189
10.1161/hypertensionaha.120.14971
10.1161/hypertensionaha.120.16249
10.1161/jaha.122.028116
10.1161/hypertensionaha.121.18776
10.1172/jci112737
10.1038/ejcn.2009.139
10.1161/atvbaha.114.304798
10.1016/j.numecd.2015.01.002
10.1161/circulationaha.118.037630
10.1016/j.jacc.2013.09.063
10.1001/jamanetworkopen.2021.3808
10.1111/obr.13449
10.1093/eurheartj/ehq024
10.1053/j.ajkd.2018.04.018
ContentType Journal Article
Copyright 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
Copyright_xml – notice: 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1161/JAHA.123.031136
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ, Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Obesity and Arterial Health After Preeclampsia
EISSN 2047-9980
ExternalDocumentID oai_doaj_org_article_7c3efd013ef249d3946aa897e8f7fdb1
PMC10727383
37929708
10_1161_JAHA_123_031136
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: CIHR
– fundername: University of Ottawa Heart Institute
– fundername: Fonds de Recherche du Québec
– fundername: Canadian Institutes for Health Research
– fundername: Association des Cardiologues du Québec
– fundername: Cardiometabolic, Obesity and Diabetes Research Network
– fundername: Laval University Dean’s Scholarship
GroupedDBID 0R~
1OC
53G
5VS
8-1
AAMMB
AAYXX
AAZKR
ACGFO
ACXQS
ADBBV
ADKYN
ADZMN
AEFGJ
AEGXH
AENEX
AGXDD
AIAGR
AIDQK
AIDYY
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GODZA
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
RAH
RNS
RPM
WIN
24P
ACCMX
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c414t-aaba61978c73c3252654727a656cec3fb61fe6231a7f0da377703c7617a6dc7e3
IEDL.DBID DOA
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001100930700023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2047-9980
IngestDate Fri Oct 03 12:53:37 EDT 2025
Tue Nov 04 02:06:12 EST 2025
Fri Sep 05 09:47:51 EDT 2025
Mon Jul 21 06:06:35 EDT 2025
Sat Nov 29 05:05:19 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 21
Keywords arterial stiffness
central obesity
arterial hemodynamics
preeclampsia
Language English
License This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c414t-aaba61978c73c3252654727a656cec3fb61fe6231a7f0da377703c7617a6dc7e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This manuscript was sent to Tiffany M. Powell‐Wiley, MD MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition.
For Sources of Funding and Disclosures, see page 10.
Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.123.031136
ORCID 0000-0002-7735-5315
0000-0001-7979-1770
0000-0003-2034-4196
OpenAccessLink https://doaj.org/article/7c3efd013ef249d3946aa897e8f7fdb1
PMID 37929708
PQID 2886598989
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_7c3efd013ef249d3946aa897e8f7fdb1
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10727383
proquest_miscellaneous_2886598989
pubmed_primary_37929708
crossref_primary_10_1161_JAHA_123_031136
PublicationCentury 2000
PublicationDate 2023-11-07
PublicationDateYYYYMMDD 2023-11-07
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-07
  day: 07
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Hoboken
PublicationTitle Journal of the American Heart Association
PublicationTitleAlternate J Am Heart Assoc
PublicationYear 2023
Publisher John Wiley and Sons Inc
Wiley
Publisher_xml – name: John Wiley and Sons Inc
– name: Wiley
References e_1_3_1_21_2
e_1_3_1_43_2
e_1_3_1_22_2
e_1_3_1_44_2
e_1_3_1_23_2
e_1_3_1_45_2
e_1_3_1_46_2
e_1_3_1_24_2
e_1_3_1_8_2
e_1_3_1_7_2
e_1_3_1_40_2
e_1_3_1_41_2
e_1_3_1_9_2
e_1_3_1_20_2
e_1_3_1_42_2
e_1_3_1_4_2
e_1_3_1_29_2
e_1_3_1_3_2
e_1_3_1_6_2
e_1_3_1_5_2
e_1_3_1_25_2
e_1_3_1_26_2
e_1_3_1_47_2
e_1_3_1_2_2
e_1_3_1_27_2
e_1_3_1_28_2
e_1_3_1_32_2
e_1_3_1_33_2
e_1_3_1_34_2
e_1_3_1_35_2
e_1_3_1_13_2
e_1_3_1_12_2
e_1_3_1_11_2
e_1_3_1_30_2
e_1_3_1_10_2
e_1_3_1_31_2
e_1_3_1_17_2
e_1_3_1_16_2
e_1_3_1_15_2
e_1_3_1_14_2
e_1_3_1_36_2
e_1_3_1_37_2
e_1_3_1_19_2
e_1_3_1_38_2
e_1_3_1_18_2
e_1_3_1_39_2
References_xml – ident: e_1_3_1_23_2
  doi: 10.1161/circulationaha.109.914507
– ident: e_1_3_1_5_2
  doi: 10.1016/j.jacc.2022.03.335
– ident: e_1_3_1_6_2
  doi: 10.1136/bmj.i1753
– ident: e_1_3_1_42_2
  doi: 10.1002/oby.20099
– ident: e_1_3_1_44_2
  doi: 10.1038/jhh.2013.81
– ident: e_1_3_1_3_2
  doi: 10.1007/s11936-018-0653-8
– ident: e_1_3_1_45_2
  doi: 10.1016/0735-1097(92)90198-v
– ident: e_1_3_1_4_2
  doi: 10.1161/circresaha.118.313276
– ident: e_1_3_1_36_2
  doi: 10.1161/hypertensionaha.116.07907
– ident: e_1_3_1_12_2
  doi: 10.1161/cir.0000000000000973
– ident: e_1_3_1_21_2
  doi: 10.1093/ajh/hpaa183
– ident: e_1_3_1_22_2
  doi: 10.1016/s0140-6736(06)68967-8
– ident: e_1_3_1_34_2
  doi: 10.1161/circresaha.120.316101
– ident: e_1_3_1_35_2
  doi: 10.1111/nure.12055
– ident: e_1_3_1_2_2
  doi: 10.1161/circresaha.116.307547
– ident: e_1_3_1_47_2
  doi: 10.1098/rspb.1922.0022
– ident: e_1_3_1_8_2
  doi: 10.2174/1573402113666170413094319
– ident: e_1_3_1_15_2
  doi: 10.1016/s0140-6736(05)67726-4
– ident: e_1_3_1_18_2
  doi: 10.1161/hypertensionaha.110.157339
– ident: e_1_3_1_38_2
  doi: 10.1152/ajpheart.00202.2020
– ident: e_1_3_1_14_2
  doi: 10.1097/aog.0000000000003891
– ident: e_1_3_1_17_2
  doi: 10.1093/eurheartj/ehl254
– ident: e_1_3_1_32_2
  doi: 10.1111/j.1471-0528.2006.01180.x
– ident: e_1_3_1_39_2
  doi: 10.1016/j.jacc.2010.11.058
– ident: e_1_3_1_26_2
  doi: 10.1161/hypertensionaha.114.03285
– ident: e_1_3_1_46_2
  doi: 10.1152/ajpheart.1986.251.3.H588
– ident: e_1_3_1_27_2
  doi: 10.1093/eurheartj/ehq165
– ident: e_1_3_1_41_2
  doi: 10.1093/eurheartj/ehm026
– ident: e_1_3_1_10_2
  doi: 10.1161/circulationaha.109.886655
– ident: e_1_3_1_31_2
  doi: 10.1371/journal.pone.0059371
– ident: e_1_3_1_37_2
  doi: 10.3390/antiox12061295
– ident: e_1_3_1_29_2
  doi: 10.1161/jaha.115.002189
– ident: e_1_3_1_9_2
  doi: 10.1161/hypertensionaha.120.14971
– ident: e_1_3_1_19_2
  doi: 10.1161/hypertensionaha.120.16249
– ident: e_1_3_1_7_2
  doi: 10.1161/jaha.122.028116
– ident: e_1_3_1_28_2
  doi: 10.1161/hypertensionaha.121.18776
– ident: e_1_3_1_24_2
  doi: 10.1172/jci112737
– ident: e_1_3_1_16_2
  doi: 10.1038/ejcn.2009.139
– ident: e_1_3_1_43_2
  doi: 10.1161/atvbaha.114.304798
– ident: e_1_3_1_13_2
  doi: 10.1016/j.numecd.2015.01.002
– ident: e_1_3_1_20_2
  doi: 10.1161/circulationaha.118.037630
– ident: e_1_3_1_30_2
  doi: 10.1016/j.jacc.2013.09.063
– ident: e_1_3_1_33_2
  doi: 10.1001/jamanetworkopen.2021.3808
– ident: e_1_3_1_40_2
  doi: 10.1111/obr.13449
– ident: e_1_3_1_11_2
  doi: 10.1093/eurheartj/ehq024
– ident: e_1_3_1_25_2
  doi: 10.1053/j.ajkd.2018.04.018
SSID ssj0000627359
Score 2.3386776
Snippet Background Women with preeclampsia have a higher risk of cardiovascular disease. This is partly explained by the worse arterial health after preeclampsia....
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e031136
SubjectTerms Aging
arterial hemodynamics
arterial stiffness
Blood Pressure
Cardiovascular Diseases
central obesity
Female
Hemodynamics
Humans
Hypertension
Obesity
Obesity, Abdominal
Original Research
Pre-Eclampsia
preeclampsia
Pregnancy
Pulse Wave Analysis
Vascular Stiffness
Title The EVA (Early Vascular Aging) Study: Association of Central Obesity With Worse Arterial Health After Preeclampsia
URI https://www.ncbi.nlm.nih.gov/pubmed/37929708
https://www.proquest.com/docview/2886598989
https://pubmed.ncbi.nlm.nih.gov/PMC10727383
https://doaj.org/article/7c3efd013ef249d3946aa897e8f7fdb1
Volume 12
WOSCitedRecordID wos001100930700023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ, Directory of Open Access Journals
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: DOA
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVWIB
  databaseName: Wiley Online Library Free Content (Freely Accessible)
  customDbUrl:
  eissn: 2047-9980
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000627359
  issn: 2047-9980
  databaseCode: WIN
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwEB1BhRAXxHfDR2UkDuUQulk7GZtbQFtVSK16gHZv1sSx1b1kq-wWqZf-dsZOWnYREhcuOSSRbPlN4jf2-D2ADyWZ6OdA-UTJNlfYhpwaY3IkTp8bqUpFIZlN4MmJns_N6YbVV6wJG-SBh4E7QCd9aONiXeBMoZVGVUTaoNcBQ9ukxIdZz0YyNfyDeVouzajlw6zm4Ft9FBf-5CeO4iIJMv-ehpJa_98o5p-VkhtTz-ETeDxyRlEPfX0K93z3DB4ej7viz6FnrMXsrBb7Sa5YnI3VpaKODkQfRawVvP4sNpAQyyDGdV0xWgOI88X6Qpwv-5WPLaXAFMMhJVFHI3Fx2nvvOIAuVwt6AT8OZ9-_HuWjl0LuVKHWOVFDnCuhdiidnEZRfMXUhZjOOe9kaKoieKZCBWGYtCQR-VfgkPkNVa1DL1_CTrfs_C4IJZlluIC6dEYpoxripHBStX4afbC8ymD_dmjt5SCZYVOqURU2omAZBTugkMGXOPR3r0Wt63SDI8COEWD_FQEZvL8FzvK3ETc8qPPLq5Wdal2VySAzg1cDkHdNSWRiiBOdgd6CeKsv20-6xUXS3-aMOR5okq__R-_fwKPoYJ-ON-Jb2Fn3V_4dPHA_14tVvwf3ca73Umzz9fhm9gsd_v5l
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+EVA+%28Early+Vascular+Aging%29+Study%3A+Association+of+Central+Obesity+With+Worse+Arterial+Health+After+Preeclampsia&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Paquin%2C+Am%C3%A9lie&rft.au=Werlang%2C+Ana&rft.au=Coutinho%2C+Thais&rft.date=2023-11-07&rft.issn=2047-9980&rft.eissn=2047-9980&rft.volume=12&rft.issue=21&rft_id=info:doi/10.1161%2FJAHA.123.031136&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_JAHA_123_031136
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon